Meningococcal NmCV-5 Vaccine is effective in 2-to-29-year-olds in Mali and Gambia
1. In this randomized controlled trial, the NmCV-5 vaccine elicited an immune response that was noninferior to the MenACWY-D vaccine ...
Tag: Mali
Monoclonal antibody CIS43LS efficacious in preventing malaria in Mali
1. The monoclonal antibody CIS43LS was associated with dose-dependent protection against malaria infection in adults in Mali. 2. CIS43LS had ...